Cargando…
Estimation of an Optimal Chemotherapy Utilisation Rate for Upper Gastrointestinal Cancers: Setting an Evidence-Based Benchmark for the Best-Quality Cancer Care
Aims. The proportion of patients with upper gastrointestinal cancers that received chemotherapy varies widely in Australia and internationally, indicating a need for a benchmark rate of chemotherapy utilisation. We developed evidence-based models for upper gastrointestinal cancers to estimate the op...
Autores principales: | Ng, Weng, Jacob, Susannah, Delaney, Geoff, Do, Viet, Barton, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4391697/ https://www.ncbi.nlm.nih.gov/pubmed/25883645 http://dx.doi.org/10.1155/2015/753480 |
Ejemplares similares
-
Benchmarking for Best Practice
por: Zairi, Mohamed
Publicado: (2010) -
Factors affecting radiotherapy utilisation in geriatric oncology patients in NSW, Australia
por: Mackenzie, Penny, et al.
Publicado: (2020) -
History of upper gastrointestinal cancers in relatives: a community-based estimate
por: Moghimi-Dehkordi, Bijan, et al.
Publicado: (2012) -
Massive Upper Gastrointestinal Bleeding
por: Shtull-Leber, Eytan, et al.
Publicado: (2022) -
References for Medical Posts–How Best to Utilise Them
por: Bourns, H. K.
Publicado: (1991)